HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389,528 | -4.6% | 3,367 | -15.2% | 0.01% | 0.0% |
| Q2 2023 | $408,417 | -18.0% | 3,971 | -13.0% | 0.01% | -20.0% |
| Q1 2023 | $498,006 | -8.3% | 4,563 | -4.4% | 0.01% | -9.1% |
| Q4 2022 | $543,167 | +170.2% | 4,773 | +47.1% | 0.01% | +175.0% |
| Q3 2022 | $201,000 | -9.0% | 3,244 | +17.2% | 0.00% | 0.0% |
| Q2 2022 | $221,000 | +7.3% | 2,767 | +41.6% | 0.00% | +33.3% |
| Q1 2022 | $206,000 | +23.4% | 1,954 | +26.1% | 0.00% | +50.0% |
| Q4 2021 | $167,000 | +145.6% | 1,550 | +149.2% | 0.00% | +100.0% |
| Q3 2021 | $68,000 | +126.7% | 622 | +95.6% | 0.00% | – |
| Q2 2021 | $30,000 | -70.0% | 318 | -70.8% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | -15.3% | 1,090 | -32.3% | 0.00% | 0.0% |
| Q4 2020 | $118,000 | -38.9% | 1,609 | -35.2% | 0.00% | -50.0% |
| Q3 2020 | $193,000 | – | 2,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |